Pure β-dicalcium silicate and monocalcium aluminate powder were prepared by Pechini method. A series of calcium silicate/calcium aluminate cements (CSC/CAC) were prepared. The setting time, crystalline phases, microstructures, compressive strength, cells attachment and silicon release of the cements were investigated. The results indicate that the setting time of CSC/CAC was shorter than that of either CSC or CAC. The hydration products in CSC/CAC composite are gehlenite (Ca2Al2SiO7·8H2O), calcium aluminate hydrate (Ca3Al2O6 × H2O), and katoite (Ca2Al2O6·6H2O). Platelike crystals were found in the microstructure. The liquid to powder ratio has a significant effect on the porosity and the strength of CSC/CAC. The MC3T3 cells attached well to the surfaces of CSC/CAC. However, the cells proliferation on the surface of 7S3A was better than that of 3S7A due to its higher silicon release. In general, CSC/CAC exhibits good biocompatibility and relative high strength, and may be suitable for some non-load bearing bone restorative applications.
IshikawaK. and AsaokaK.: ‘Estimation of ideal mechanical strength and critical porosity of calcium phosphate cement’, J. Biomed. Mater. Res., 1995, 29, (12), 1537–1543. doi: 10.1002/jbm.820291210
2.
PiecuchJ. F.: ‘Extraskeletal of a porous hydroxyapatite ceramic’, J. Dent. Res., 1982, 61, (12), 1458–1460. doi: 10.1177/00220345820610121801
3.
KitsugiT., YamamuroT., TakeuchiH. and OnoM.: ‘Bonding behavior of three types of hydroxyapatite with different sintering temperatures implanted in bone’, Clin. Orthop. Relat. Res., 1988, 234, 280–290.
4.
WuF., WeiJ., GuoH., ChenF. P., HongH. and LiuC. S.: ‘Self-setting bioactive calcium–magnesium phosphate cement with high strength and degradability for bone regeneration’, Acta Biomater., 2008, 4, (6), 1873–1884. doi: 10.1016/j.actbio.2008.06.020
5.
RatnerBuddy D., HoffmanAllan S., SchoenFrederick J. and LemonsJ. E.: ‘Biomaterials science: an introduction to materials in medicine’, 3rd edn; 2013, Oxford, Academic Press.
LiX., ShiJ., ZhuY., ShenW., LiH., LiangJ. and GaoJ.: ‘A template route to the preparation of mesoporous amorphous calcium silicate with high in vitro bone-forming bioactivity’, J. Biomed. Mater. Res. B, 2007, 83B, (2), 431–439. doi: 10.1002/jbm.b.30813
8.
SprioS., TampieriA., CelottiG. and LandiE.: ‘Development of hydroxyapatite/calcium silicate composites addressed to the design of load-bearing bone scaffolds’, J. Mech. Behav. Biomed. Mater., 2009, 2, (2), 147–155. doi: 10.1016/j.jmbbm.2008.05.006
9.
TaddeiP., TintiA., GandolfiM. G., RossiP. L. and PratiC.: ‘Ageing of calcium silicate cements for endodontic use in simulated body fluids: a micro-Raman study’, J. Raman Spectrosc., 2009, 40, (12), 1858–1866. doi: 10.1002/jrs.2333
10.
WuJ., ZhuY. J., ChenF., ZhaoX. Y., ZhaoJ. and QiC.: ‘Amorphous calcium silicate hydrate/block copolymer hybrid nanoparticles: synthesis and application as drug carriers’, Dalton Trans., 2013, 42, (19), 7032–7040. doi: 10.1039/c3dt50143d
11.
HughesE., YanniT., JamshidiP. and GroverL.: ‘Inorganic cements for biomedical application: calcium phosphate, calcium sulphate and calcium silicate’, Adv. Appl. Ceram., 2015, 114, (2), 65–76. doi: 10.1179/1743676114Y.0000000219
12.
TanY., YongL., QingZ., BirdiG. and GroverL. M.: ‘Synthesis of pure dicalcium silicate powder by the Pechini method and characterization of hydrated cement’, Mater. Sci. Forum, 2014, Trans Tech Publ, 387–394. doi: 10.4028/www.scientific.net/MSF.787.387
13.
DingS. J., ShieM. Y. and WangC. Y.: ‘Novel fast-setting calcium silicate bone cements with high bioactivity and enhanced osteogenesis in vitro’, J. Mater. Chem., 2009, 19, (8), 1183–1190. doi: 10.1039/b819033j
14.
CorreaD., AlmirallA., Garcia-CarrodeguasR., Alberto Dos SantosL., De AzaA. H., ParraJ. and Angel DelgadoJ.: ‘Beta-dicalcium silicate-based cement: synthesis, characterization and in vitro bioactivity and biocompatibility studies’, J. Biomed. Mater. Res. A, 2014, 102, (10), 3693–3703. doi: 10.1002/jbm.a.35041
15.
NettleshipI., ShullJ. L. and KrivenW. M.: ‘Chemical preparation and phase-stability of Ca2SiO4 and Sr2SiO4 powders’, J. Eur. Ceram. Soc., 1993, 11, (4), 291–298. doi: 10.1016/0955-2219(93)90028-P
16.
TanY., LiuY., ZhangZ., HofmannM. and GroverL.: ‘Comparing three methods for the synthesis of pure β-dicalcium silicate’, 4rd International Conference on Bioinformatics and Biomedical Engineering, iCBBE 2010, 2010.
Van DijkenJ. W. and Sunnegårdh-GrönbergK.: ‘A three year follow-up of posterior doxadent restorations’, Swiss dent., 2005, 29, (2), 45–51.
19.
FranzA., KonradssonK., KonigF., Van DijkenJ. W. V. and SchedleA.: ‘Cytotoxicity of a calcium aluminate cement in comparison with other dental cements and resin-based materials’, Acta Odontol. Scand., 2006, 64, (1), 1–8. doi: 10.1080/00016350500279568
20.
LoofJ., EngqvistH., AhnfeltN. O., LindqvistK. and HermanssonL.: ‘Mechanical properties of a permanent dental restorative material based on calcium aluminate’, J. Mater. Sci.-Mater. Med., 2003, 14, (12), 1033–1037. doi: 10.1023/B:JMSM.0000003999.52349.0d
21.
TanY., LiuY., ZhangZ., HuangB. and GroverL. M.: ‘hydroxyapatite formation on surface of calcium aluminate cements’, Adv. Appl. Ceram., 2011, 110, (8), 464–468. doi: 10.1179/1743676111Y.0000000033
OhS. H., ChoiS. Y., LeeY. K., KimK. N. and ChoiS. H.: ‘Effects of lithium fluoride and maleic acid on the bioactivity of calcium aluminate cement: formation of hydroxyapatite in simulated body fluid’, J. Biomed. Mater. Res. A, 2003, 67A, (1), 104–111. doi: 10.1002/jbm.a.10036
24.
OhS. H., ChoiS. Y., LeeY. K. and KimK. N.: ‘Preparation of calcium aluminate cement for hard tissue repair: effects of lithium fluoride and maleic acid on setting behavior, compressive strength, and biocompatibility’, J. Biomed. Mater. Res., 2002, 62, (4), 593–599. doi: 10.1002/jbm.10347
25.
DamidotD. and GlasserF. P.: ‘Investigation of the CaO–Al2O3–SiO2–H2O system at 25°C by thermodynamic calculations’, Cement Concrete Res., 1995, 25, (1), 22–28. doi: 10.1016/0008-8846(94)00108-B
26.
SkibstedJ., HendersonE. and JakobsenH. J.: ‘Characterization of calcium aluminate phases in cements by aluminum-27 MAS NMR spectroscopy’, Inorg. Chem., 1993, 32, (6), 1013–1027. doi: 10.1021/ic00058a043
27.
MatusinovicT., SipusicJ. and VrbosN.: ‘Porosity-strength relation in calcium aluminate cement pastes’, Cement Concrete Res., 2003, 33, (11), 1801–1806. doi: 10.1016/S0008-8846(03)00201-1
28.
GouZ., ChangJ., ZhaiW. and WangJ.: ‘Study on the self-setting property and the in vitro bioactivity of beta-Ca2SiO4’, J. Biomed. Mater. Res. B, 2005, 73B, (2), 244–251. doi: 10.1002/jbm.b.30203
29.
VillacampaA. I. and Garcı´a-Ruiz:J. M. ‘Synthesis of a new hydroxyapatite-silica composite material’, J. Cryst. Growth, 2000, 211, (1), 111–115. doi: 10.1016/S0022-0248(99)00793-9
30.
SousaA., SouzaK. and SousaE.: ‘Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery’, Acta Biomater., 2008, 4, (3), 671–679. doi: 10.1016/j.actbio.2007.11.003
31.
SaenzA., MonteroM. and CastanoV.: ‘Preparation of silica–hydroxyapatite nanometric composites’, Phys. Status Solidi B, 2002, 230, (2), 347–350. doi: 10.1002/1521-3951(200204)230:2<347::AID-PSSB347>3.0.CO;2-I
32.
NingC., MehtaJ. and El-GhannamA.: ‘Effects of silica on the bioactivity of calcium phosphate composites in vitro’, J. Mater. Sci.-Mater. Med., 2005, 16, (4), 355–360. doi: 10.1007/s10856-005-0635-8
